| 1 | 99000-04-1 | 1,2-Ethanediamine, N1,N1-bis(2-chloroethyl)-N2,N2-dicyclohexyl-, hydrochloride (1:2) | C18H35Cl3N2 | 385.84 | | |
| 2 | 99000-09-6 | (E)-N'-(2-hydroxybenzylidene)-2-(2-isopropyl-5-methylphenoxy)acetohydrazide | C19H22N2O3 | 326.39 | | |
| 3 | 99004-00-9 | Dopamine Impurity 4 | C18H19NO4 | 313.35 | 72-75 °C | |
| 4 | 99006-57-2 | ethyl [3-phenyl-4,5-bis(phenylimino)-2-thioxoimidazolidin-1-yl]acetate | C25H22N4O2S | 442.53278 | | |
| 5 | 99006-65-2 | ethyl3-(4,5-dioxo-3-phenyl-2-thioxo-1-imidazolidinyl)propanoate | C14H14N2O4S | 306.33696 | | |
| 6 | 99006-71-0 | 1-(4-fluorophenyl)-3-(4-methoxyphenyl)-4,5-bis[(4-methoxyphenyl)imino]imidazolidine-2-thione | C30H25FN4O3S | 540.6079032 | | |
| 7 | 99006-73-2 | 1-phenyl-4,5-bis(phenylimino)imidazolidine-2-thione | C21H16N4S | 356.44354 | | |
| 8 | 99006-74-3 | 1-benzoyl-3-phenyl-4,5-bis(phenylimino)imidazolidine-2-thione | C28H20N4OS | 460.5496 | | |
| 9 | 99006-75-4 | 1-(4-chlorobenzoyl)-4,5-bis[(4-methoxyphenyl)imino]-3-phenylimidazolidine-2-thione | C30H23ClN4O3S | 555.04662 | | |
| 10 | 99006-78-7 | 4,5-bis[(4-methoxyphenyl)imino]-1-[(4-methylphenyl)sulfonyl]-3-phenylimidazolidine-2-thione | C30H26N4O4S2 | 570.68184 | | |
| 11 | 99007-02-0 | N'-(9-anthrylmethylene)-N-phenylcarbamohydrazonothioic acid | C22H17N3S | 355.45548 | | |
| 12 | 99007-18-8 | 1H-Pyrazole-4-carbonyl chloride, 3-amino-1-(2-butenyl)- (9CI) | C8H10ClN3O | 199.64 | | |
| 13 | 99007-42-8 | Undecanoic acid 3-hydroxy-2,2-bis(hydroxymethyl)propyl ester | C16H32O5 | 304.42 | | |
| 14 | 99007-44-0 | Pentadecanoic acid 3-hydroxy-2,2-bis(hydroxymethyl)propyl ester | C20H40O5 | 360.53 | | |
| 15 | 99007-73-5 | 2-octylundecanol | C19H40O | 284.53 | | |
| 16 | 99007-75-7 | 2-decyl-1-dodecanol | C22H46O | 326.6 | | |
| 17 | 99007-84-8 | ETHYL 2-[(4-OXO-3-PHENYL-4H-CHROMEN-7-YL)OXY]PROPIONATE | C20H18O5 | 338.35 | | |
| 18 | 99007-90-6 | 2-[(4-OXO-3-PHENYL-4H-CHROMEN-7-YL)OXY]PROPANOIC ACID | C18H14O5 | 310.3 | | |
| 19 | 99008-43-2 | 1H-Isoindole-1,3(2H)-dione, 2-(4-aminobutyl)- | C12H14N2O2 | 218.25 | | |
| 20 | 99008-52-3 | Ethanol, 2-[[2-(5-nitropyrazolo[3,4,5-kl]acridin-2(6H)-yl)ethyl]amino]- | C17H17N5O3 | 339.35 | | |
| 21 | 99008-55-6 | Pyrazolo[3,4,5-kl]acridine-2(6H)-ethanamine, N,N-diethyl-9-methoxy-5-nitro- | C20H23N5O3 | 381.43 | | |
| 22 | 99008-65-8 | Pyrazolo[3,4,5-kl]acridin-9-ol, 2-[2-(diethylamino)ethyl]-2,6-dihydro-5-nitro- | C19H21N5O3 | 367.4 | | |
| 23 | 99008-87-4 | Propanoic acid, 2,2-dimethyl-, 2-[2-(diethylamino)ethyl]-2,6-dihydro-5-nitropyrazolo[3,4,5-kl]acridin-9-yl ester | C24H29N5O4 | 451.52 | | |
| 24 | 99009-18-4 | Pyrazolo[3,4,5-kl]acridin-9-ol, 2-[3-(dimethylamino)propyl]-2,6-dihydro-5-nitro- | C18H19N5O3 | 353.38 | | |
| 25 | 99009-20-8 | NSC 366140 | C19H21N5O3 | 367.4 | | |
| 26 | 99009-21-9 | Pyrazoloacridine | C20H25N5O6S | 463.51 | | |
| 27 | 99009-49-1 | 8-Chloro-5-nitro-acridin-2,9-diol | C13H7ClN2O4 | 290.66 | | |
| 28 | 99009-85-5 | 4-Isobutylamino-3-nitroquinoline | C13H15N3O2 | 245.28 | 119-121 °C(Solv: ethyl acetate (141-78-6); hexane (110-54-3)) | |
| 29 | 99009-87-7 | 3-nitro-4-hydroxyethylaminoquinoline | C11H11N3O3 | 233.22 | 204-207 °C | |
| 30 | 99009-89-9 | 4-Quinolinamine, N-ethyl-3-nitro- | C11H11N3O2 | 217.22 | | |
| 31 | 99009-92-4 | 6-FLUORO-N-METHYL-3-NITROQUINOLIN-4-AMINE | C10H8FN3O2 | | | |
| 32 | 99009-93-5 | N-BENZYL-3-NITROQUINOLIN-4-AMINE | C15H11N3O2 | 265.27 | 129-132 °C | |
| 33 | 99009-96-8 | Imiquimod Impurity 8 | C13H15N3O2 | 245.28 | | |